Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Fosfomycin
Drug ID BADD_D00965
Description Fosfomycin was discovered in 1969 by scientists at the Spanish Penicillin and Antibiotics Company and is produced by _Streptomyces fradiae_.[A229338,A230348] It may also be produced synthetically and is commercially available as the disodium salt for intravenous administration and as the calcium or trometamol salt for oral administration.[A230348] In terms of chemical structure, fosfomycin is a phosphoenolpyruvate analog and contains a phosphonic group and an epoxide ring.[A230348] Due to its ease of administration as a single 3-gram oral dose and desirable safety profile, fosfomycin has largely become a first-line therapeutic option for the treatment of uncomplicated urinary tract infections (UTIs) in females.[A230378] Despite being FDA approved only for urinary tract infections, fosfomycin actually has a broad spectrum of activity and is active against both gram-positive and gram-negative bacteria.[A230348] As such there is great interest in exploring the usefulness of fosfomycin for indications beyond the treatment of UTIs.[A230353,A230358]
Indications and Usage Fosfomycin is indicated for the treatment of uncomplicated cases of cystitis caused by susceptible strains of _Escherichia coli_ and _Enterococcus faecalis_.[L31818] Fosfomycin is not officially indicated for the treatment of pyelonephritis or perinephric abscess, although there have been reported cases of off-label usage in these situations.[L31818]
Marketing Status approved
ATC Code J01XX01; S02AA17
DrugBank ID DB00828
KEGG ID D04253
MeSH ID D005578
PubChem ID 446987
TTD Drug ID D01GYT
NDC Product Code Not Available
UNII 2N81MY12TE
Synonyms Fosfomycin | Phosphomycin | Phosphonomycin | Monuril | Fosfomycin Trometamol Salt | Fosfomycin Tromethamine | Tromethamine, Fosfomycin
Chemical Information
Molecular Formula C3H7O4P
CAS Registry Number 23155-02-4
SMILES CC1C(O1)P(=O)(O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Pyrexia08.05.02.0030.000066%
Rash23.03.13.0010.000132%-
Rash pruritic23.03.13.0300.000099%-
Rhinitis11.01.13.004; 22.07.03.006--
Skin disorder23.03.03.007---
Somnolence17.02.04.006; 19.02.05.003--
Tension19.06.02.005---
Urticaria10.01.06.001; 23.04.02.0010.000198%
Vaginal infection11.01.10.002; 21.14.02.002--
Vomiting07.01.07.0030.000099%
White blood cell count decreased13.01.06.012--
Hypoacusis04.02.01.006--
Musculoskeletal discomfort15.03.04.001---
Blood alkaline phosphatase increased13.04.02.004--
Decreased appetite08.01.09.028; 14.03.01.005--
Adverse drug reaction08.06.01.009---
Acute kidney injury20.01.03.0160.000066%
Vulvovaginal inflammation21.14.02.014---
The 3th Page    First    Pre   3    Total 3 Pages